Press-release for stocks publishing date 2022 - 03

Prices are updated after-hours

PTC Therapeutics Announces Initiation of PIVOT-HD Phase 2 Clinical Trial to Evaluate PTC518 in Patients with Huntington's Disease
Published: 2022-03-30 (Crawled : 21:00) - biospace.com/
PTCT | News S | $25.19 -0.87% -0.87% 560K

| -33.21% | O: -0.21% H: 0.01% C: -3.81%
ptc518 disease trial therapeutics phase 2 huntington’s disease

ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
Published: 2022-03-30 (Crawled : 16:00) - biospace.com/
PRPH | $5.12 -0.78% -0.78% 16K

| -28.33% | O: 3.89% H: 4.28% C: -5.75%
results

TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Conference
Published: 2022-03-30 (Crawled : 16:00) - biospace.com/
TELA | $4.47 0.0% 85K

| -61.63% | O: 0.0% H: 0.6% C: 0.6%
conference

Trevena to Release Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022
Published: 2022-03-30 (Crawled : 13:00) - biospace.com/
TRVN | $0.371 -4.38% -4.58% 61K

| -16.02% | O: 1.21% H: 0.0% C: -6.13%
results

Cognition Therapeutics Reports Year End 2021 Financial Results and Provides Business Update
Published: 2022-03-30 (Crawled : 13:00) - biospace.com/
CGTX | News | $2.0 0.0% 110K

| -32.66% | O: -6.39% H: 17.98% C: -4.32%
therapeutics results

BiomX Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-30 (Crawled : 11:00) - biospace.com/
PHGE | $0.3274 -5.51% 3.82% 130K

| -77.12% | O: -3.27% H: 22.97% C: 18.24%
results

62%

38%

CSSE 4 | $0.4323 183.85% 64.77% 220M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.